DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Klotz L, O'Callaghan C, Ding K. et al.
Nadir testosterone within first year of androgen-deprivation therapy (ADT)
predicts for time to castration-resistant progression: a secondary analysis of the PR-7
trial of intermittent versus continuous ADT.
J Clin Oncol 2015;
33: 1151-1156
DOI: 10.1200/JCO.2014.58.2973. (PMID: 25732157)
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.